Production and characterization of biosurfactants from Bacillus licheniformis F2.2
- PMID: 12843648
- DOI: 10.1271/bbb.67.1239
Production and characterization of biosurfactants from Bacillus licheniformis F2.2
Abstract
A biosurfactant-producing strain, Bacillus licheniformis F2.2, was isolated from a fermented food in Thailand. The strain was capable of producing a new biosurfactant, BL1193, as well as two kinds of popular lipopeptide biosurfactants, plipastatin and surfactin. Mass spectrometry and FT-IR analysis indicated that BL1193 had a molecular mass of 1,193 Da with no peptide portion in the molecule. While plipastatin and surfactin were abundantly produced in a nutrient YPD medium, BL1193 was produced only in a synthetic DF medium containing no amino acids. According to an oil displacement activity test, the specific activity of BL1193 (6.53 kBS units/mg) is equivalent to that of surfactin (5.78-6.83 kBS units/mg).
Similar articles
-
Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry.J Antibiot (Tokyo). 1999 Apr;52(4):363-73. doi: 10.7164/antibiotics.52.363. J Antibiot (Tokyo). 1999. PMID: 10395272
-
Isolation and characterization of a halotolerant Bacillus subtilis BBK-1 which produces three kinds of lipopeptides: bacillomycin L, plipastatin, and surfactin.Extremophiles. 2002 Dec;6(6):499-506. doi: 10.1007/s00792-002-0287-2. Epub 2002 Sep 13. Extremophiles. 2002. PMID: 12486459
-
Production of lipopeptide biosurfactants by Bacillus atrophaeus 5-2a and their potential use in microbial enhanced oil recovery.Microb Cell Fact. 2016 Oct 3;15(1):168. doi: 10.1186/s12934-016-0574-8. Microb Cell Fact. 2016. PMID: 27716284 Free PMC article.
-
Toxicity and applications of surfactin for health and environmental biotechnology.J Toxicol Environ Health B Crit Rev. 2018;21(6-8):382-399. doi: 10.1080/10937404.2018.1564712. Epub 2019 Jan 7. J Toxicol Environ Health B Crit Rev. 2018. PMID: 30614421 Review.
-
Bacillus licheniformis: The unexplored alternative for the anaerobic production of lipopeptide biosurfactants?Biotechnol Adv. 2022 Nov;60:108013. doi: 10.1016/j.biotechadv.2022.108013. Epub 2022 Jun 22. Biotechnol Adv. 2022. PMID: 35752271 Review.
Cited by
-
Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications.Pharmaceutics. 2023 Jul 5;15(7):1893. doi: 10.3390/pharmaceutics15071893. Pharmaceutics. 2023. PMID: 37514078 Free PMC article. Review.
-
Protective effects of Bacillus licheniformis on growth performance, gut barrier functions, immunity and serum metabolome in lipopolysaccharide-challenged weaned piglets.Front Immunol. 2023 Mar 22;14:1140564. doi: 10.3389/fimmu.2023.1140564. eCollection 2023. Front Immunol. 2023. PMID: 37033995 Free PMC article.
-
The Effects of Bacillus licheniformis-Fermented Products on the Microbiota and Clinical Presentation of Cats with Chronic Diarrhea.Animals (Basel). 2022 Aug 25;12(17):2187. doi: 10.3390/ani12172187. Animals (Basel). 2022. PMID: 36077904 Free PMC article.
-
Genetic Evidences of Biosurfactant Production in Two Bacillus subtilis Strains MB415 and MB418 Isolated From Oil Contaminated Soil.Front Bioeng Biotechnol. 2022 Apr 26;10:855762. doi: 10.3389/fbioe.2022.855762. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35557861 Free PMC article.
-
Effectiveness of Bacillus licheniformis-Fermented Products and Their Derived Antimicrobial Lipopeptides in Controlling Coccidiosis in Broilers.Animals (Basel). 2021 Dec 16;11(12):3576. doi: 10.3390/ani11123576. Animals (Basel). 2021. PMID: 34944351 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous

